Core Laboratories (CLB) Projected to Release Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB) is expected to be releasing its Q3 2026 results after the market closes on Wednesday, October 28th. Analysts expect the company to announce earnings of $0.1618 per share and revenue of $131.87 million for the quarter. Core Laboratories has set its Q3 2026 guidance at 0.120-0.200 EPS. Interested persons can check the company’s upcoming Q3 2026 earnings overview page for the latest details on the call scheduled for Thursday, October 29, 2026 at 8:30 AM ET.

Core Laboratories (NYSE:CLB) last issued its quarterly earnings results on Wednesday, July 29th. The oil and gas company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.09 by $0.02. Core Laboratories had a return on equity of 10.03% and a net margin of 5.10%. The company had revenue of $124.61 million during the quarter, compared to analyst estimates of $126.26 million. During the same period in the previous year, the company earned $0.19 earnings per share. The company’s quarterly revenue was down 4.3% compared to the same quarter last year. On average, analysts expect Core Laboratories to post $0.56 EPS for the current fiscal year and $0.79 EPS for the next fiscal year.

Core Laboratories Stock Down 0.2%

CLB opened at $9.89 on Monday. The business has a 50 day moving average of $11.21 and a 200-day moving average of $12.46. The stock has a market capitalization of $453.89 million, a price-to-earnings ratio of 17.67, a P/E/G ratio of 1.98 and a beta of 1.14. The company has a current ratio of 2.12, a quick ratio of 1.55 and a debt-to-equity ratio of 0.41. Core Laboratories has a 1-year low of $9.13 and a 1-year high of $20.36.

Core Laboratories Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Monday, August 31st. Investors of record on Monday, August 10th were given a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, August 10th. This represents a $0.04 dividend on an annualized basis and a yield of 0.4%. Core Laboratories’s payout ratio is 7.14%.

Insider Buying and Selling

In other news, CEO Lawrence Bruno purchased 5,000 shares of the business’s stock in a transaction on Friday, July 31st. The stock was purchased at an average price of $10.78 per share, with a total value of $53,900.00. Following the acquisition, the chief executive officer directly owned 262,438 shares in the company, valued at approximately $2,829,081.64. The trade was a 1.94% increase in their position. The purchase was disclosed in a filing with the SEC, which is accessible through this link. 1.26% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

A number of brokerages have weighed in on CLB. Weiss Ratings downgraded shares of Core Laboratories from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, October 2nd. Wall Street Zen upgraded shares of Core Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, August 1st. Finally, Johnson Rice upgraded shares of Core Laboratories from a “hold” rating to a “buy” rating and set a $21.00 price objective on the stock in a report on Thursday, August 13th. One analyst has rated the stock with a Buy rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, Core Laboratories has an average rating of “Hold” and an average target price of $21.00.

Core Laboratories Company Profile

Core Laboratories N.V. (NYSE: CLB) is a global provider of proprietary reservoir description and production enhancement services and products for the energy industry. The company helps oil and natural gas producers evaluate reservoirs, improve well performance, and optimize the recovery of hydrocarbons.

Its reservoir description activities include geological and geochemical analysis, petrophysical services, core and fluid analysis, and laboratory testing used to characterize subsurface formations.